Trailing-twelve-month (TTM) revenue is $2.91 Billion with a year-over-year growth of (31.68%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-08-30 | $922,602,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-01 |
| Q2 FY2026Period ended 2025-11-29 | $769,498,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-07 |
| Q3 FY2026Period ended 2026-02-28 | $666,951,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-01 |
| Q4 FY2026Period ended 2026-05-30 | $552,581,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-22 |
| TTM revenue | $2,911,632,000 |
Current P/S: $3,490,163,069 market capitalization ÷ $2,911,632,000 TTM revenue = 1.20x.
Market capitalization source: FMP quote. Quote observed 2026-09-15T20:00:01.000Z. Latest revenue period ended 2026-05-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-05-30): $552.58M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T22:35:20.029Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-05-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-05-30 · USD | FY20212021-05-29 · USD | FY20222022-05-28 · USD | FY20232023-06-03 · USD | FY20242024-06-01 · USD | FY20262026-05-30 · USD |
|---|---|---|---|---|---|---|
| Egg Products | $31M | $37M | $60M | $122M | $89M | N/A |
| Food And Beverage | N/A | N/A | N/A |
$2.91B
$2.91 Billion
(31.68%)
vs. $4.26B a year ago (TTM)
+14.16%
5 Year compound annual growth rate
1 Year
(31.68%)
3 Year
(1.42%)
5 Year
+14.16%
10 Year
+3.69%
15 Year
+7.83%
20 Year
+9.91%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.91B | ($1.35B) | (31.68%) |
| 2025 | $4.26B | +$1.94B | +83.19% |
| 2024 | $2.33B | ($819.77M) | (26.06%) |
| 2023 | $3.15B | +$1.37B | +77.04% |
| 2022 | $1.78B | +$428.17M | +31.74% |
| 2021 |
TTM Growth
(31.68%)
3-Year CAGR
(1.42%)
5-Year CAGR
+14.16%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-15T22:35:20.029Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
| N/A |
| N/A |
| $450M |
| Non-Specialty Shell Egg Sales | $830M | $766M | N/A | N/A | $1.3B | N/A |
|---|
| Other | $4M | $6M | $6M | $15M | $20M | N/A |
|---|
| Retail | N/A | N/A | N/A | N/A | N/A | $2.4B |
|---|
| Service Other | N/A | N/A | N/A | N/A | N/A | $72M |
|---|
| Specialty Shell Egg Sales | $485M | $540M | $649M | $957M | $926M | N/A |
|---|
| $1.35B |
| ($2.62M) |
| (0.19%) |
| 2020 | $1.35B | ($9.58M) | (0.70%) |
| 2019 | $1.36B | ($141.74M) | (9.43%) |
| 2018 | $1.50B | +$428.42M | +39.87% |
| 2017 | $1.07B | ($834.14M) | (43.70%) |
